Table 3.
Mortality rate by each follow-up and cancer subgroup
| PE | Baseline | Month 1 | Month 3 | Month 6 | Month 12 |
|---|---|---|---|---|---|
| All | |||||
| Total | 1398 | 1388 | 1327 | 1307 | 1263 |
| Death, n(%) | 14 (1.00) | 34 (2.45) | 59 (4.45) | 79 (6.04) | 102 (8.08) |
| Reason for death | |||||
| Missing/unknown | – | 2 (5.9) | 2 (3.4) | 4 (5.1) | 6 (5.9) |
| VTE-related death | 5 (35.7) | 6 (17.6) | 7 (11.9) | 7 (8.9) | 7 (6.9) |
| Cardiovascular death | 3 (21.4) | 5 (14.7) | 9 (15.3) | 12 (15.2) | 18 (17.6) |
| Other | 6 (42.9) | 21 (61.8) | 41 (69.5) | 56 (70.9) | 71 (69.6) |
| Without active cancer | |||||
| Total | 1278 | 1270 | 1213 | 1194 | 1151 |
| Death, n(%) | 11 (0.86) | 23 (1.81) | 38 (3.13) | 45 (3.8) | 54 (4.69) |
| Reason for death | |||||
| Missing/unknown | – | 1 (4.3) | 1 (2.6) | 3 (6.7) | 2 (3.7) |
| VTE-related death | 5 (45.5) | 6 (26.1) | 6 (15.8) | 6 (13.3) | 6 (11.1) |
| Cardiovascular death | 2 (18.2) | 4 (17.4) | 8 (21.1) | 11 (24.4) | 13 (24.1) |
| Other | 4 (36.4) | 12 (52.2) | 23 (60.5) | 25 (55.6) | 30 (55.6) |
| With active cancer | |||||
| Total | 120 | 118 | 114 | 113 | 112 |
| Death, n(%) | 3 (2.5) | 11 (9.32) | 21 (18.4) | 34 (30.1) | 48 (42.9) |
| Reason for death | |||||
| Missing/unknown | – | 1 (9.1) | 1 (4.8) | 1 (2.9) | 4 (8.3) |
| VTE-related death | – | – | 1 (4.8) | 1 (2.9) | 1 (2.1) |
| Cardiovascular death | 1 (33.3) | 1 (9.1) | 1 (4.8) | 1 (2.9) | 5 (10.4) |
| Other | 2 (66.7) | 9 (81.8) | 18 (85.7) | 31 (91.2) | 41 (85.4) |
VTE venous thromboembolism